FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Our End-of-Phase 2 meeting with FDA was productive and provided Lexicon with the insights needed to design a robust Phase 3 program, with the goal of making the first non-opioid DPNP medicine ...
Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
Forbes contributors publish independent expert analyses and insights. Kathleen Walch covers AI, ML, and big data best practices. The pharmaceutical industry, known for its rigorous research, complex ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (RDW), a leader in space infrastructure for the next-generation space economy, has been awarded a NASA contract to launch four additional ...
The Chosun Ilbo on MSN
NVIDIA, Eli Lilly partner on physical AI drug development
On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...
Budget and staffing cuts at the Food and Drug Administration orchestrated by President Donald Trump could prevent new drugs “from being developed, approved, or commercialized in a timely manner, or at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback